MARGONI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.546
AS - Asia 2.021
EU - Europa 1.468
SA - Sud America 547
AF - Africa 536
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 26
Totale 7.194
Nazione #
US - Stati Uniti d'America 2.270
SG - Singapore 732
IT - Italia 502
BR - Brasile 334
CN - Cina 313
HK - Hong Kong 243
VN - Vietnam 139
DE - Germania 91
NL - Olanda 81
PL - Polonia 67
FI - Finlandia 62
FR - Francia 62
SE - Svezia 57
TR - Turchia 51
GB - Regno Unito 44
IN - India 41
KR - Corea 41
RU - Federazione Russa 39
AR - Argentina 36
EC - Ecuador 35
MX - Messico 35
AT - Austria 33
CI - Costa d'Avorio 26
PE - Perù 26
BJ - Benin 25
JO - Giordania 25
UA - Ucraina 24
ES - Italia 23
VE - Venezuela 23
EG - Egitto 22
IE - Irlanda 22
IQ - Iraq 22
JP - Giappone 22
AL - Albania 21
CH - Svizzera 21
MK - Macedonia 21
ZA - Sudafrica 21
CA - Canada 20
CR - Costa Rica 20
MR - Mauritania 20
RO - Romania 20
TJ - Tagikistan 20
AO - Angola 19
BD - Bangladesh 19
MY - Malesia 19
PT - Portogallo 19
PY - Paraguay 19
AZ - Azerbaigian 18
DK - Danimarca 18
IS - Islanda 18
ME - Montenegro 18
PS - Palestinian Territory 18
TN - Tunisia 18
DZ - Algeria 17
ET - Etiopia 17
HN - Honduras 17
ID - Indonesia 17
IR - Iran 17
KZ - Kazakistan 17
PH - Filippine 17
BO - Bolivia 16
BZ - Belize 16
CO - Colombia 16
NC - Nuova Caledonia 16
RS - Serbia 16
TW - Taiwan 16
XK - ???statistics.table.value.countryCode.XK??? 16
ZW - Zimbabwe 16
BE - Belgio 15
GF - Guiana Francese 15
HU - Ungheria 15
LA - Repubblica Popolare Democratica del Laos 15
MD - Moldavia 15
UY - Uruguay 15
ZM - Zambia 15
GT - Guatemala 14
IL - Israele 14
JM - Giamaica 14
LC - Santa Lucia 14
LV - Lettonia 14
LY - Libia 14
MA - Marocco 14
NI - Nicaragua 14
PK - Pakistan 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
BF - Burkina Faso 13
CD - Congo 13
CM - Camerun 13
CY - Cipro 13
EE - Estonia 13
GA - Gabon 13
GE - Georgia 13
MN - Mongolia 13
NA - Namibia 13
NE - Niger 13
SK - Slovacchia (Repubblica Slovacca) 13
SO - Somalia 13
BA - Bosnia-Erzegovina 12
BY - Bielorussia 12
Totale 6.640
Città #
Singapore 422
Ashburn 362
Fairfield 269
Hong Kong 238
Chandler 165
Woodbridge 135
Santa Clara 134
Cambridge 98
Beijing 94
Houston 94
Seattle 86
Milan 82
Wilmington 56
Hefei 53
Ho Chi Minh City 50
Boardman 49
Munich 47
Los Angeles 46
Ann Arbor 45
Bytom 37
Istanbul 33
Chicago 31
São Paulo 31
Rome 29
Medford 28
Princeton 28
Helsinki 27
Abidjan 25
Amman 25
Cotonou 25
Roxbury 25
Hanoi 24
Buffalo 23
Padova 22
Dushanbe 20
San Diego 20
Turku 20
Nouakchott 19
Seoul 19
Vienna 19
Baku 18
Des Moines 18
Salt Lake City 17
Cagliari 16
Dublin 16
Guangzhou 16
New York 16
Redondo Beach 16
Harare 15
Lima 15
Luanda 15
Lusaka 15
Noumea 15
Castries 14
Nuremberg 14
Paris 14
Podgorica 14
San José 14
Skopje 14
Verona 14
Vientiane 14
Warsaw 14
Brooklyn 13
Mexico City 13
Quito 13
Reykjavik 13
Riga 13
Addis Ababa 12
Bishkek 12
Cayenne 12
Guayaquil 12
Kampala 12
Managua 12
Rio de Janeiro 12
Shanghai 12
Tallinn 12
Tirana 12
Ulan Bator 12
Chennai 11
Havana 11
Libreville 11
Maputo 11
Montevideo 11
Montreal 11
Niamey 11
Pristina 11
The Dalles 11
Tokyo 11
Asunción 10
Belize City 10
Bologna 10
Bridgetown 10
Chisinau 10
Kinshasa 10
Kuala Lumpur 10
Nassau 10
Ouagadougou 10
Panama City 10
Tashkent 10
Amsterdam 9
Totale 3.815
Nome #
Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot Study 349
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis 203
Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset. 193
A new Italian family with HTRA1 mutation associated with autosomal-dominant variant of CARASIL: Are we pointing towards a disease spectrum? 187
No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab 173
Early red nucleus atrophy in relapse-onset multiple sclerosis 168
Selective Cerebellar Atrophy Associates with Depression and Fatigue in the Early Phases of Relapse-Onset Multiple Sclerosis 166
Isolated choroid plexus involvement in a case of granulomatosis with polyangiitis negative for antineutrophil cytoplasmic antibodies (ANCA) 158
Slowly Progressive Optic Perineuritis as the First Clinical Manifestation of Sarcoidosis 155
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study 153
Ophthalmoplegic migraine: Could electroencephalogram still be a useful tool to better understand the pathogenetic mechanism? 150
Neurite orientation dispersion and density imaging discloses early changes in the normal-appearing white matter in paediatric multiple sclerosis 150
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 149
Quantificazione del danno microstrutturale nella sclerosi multipla attraverso il rapporto delle sequenze pesate in T1 e T2: uno studio multicentrico 148
Neuropsychological awareness in pediatrics (NAP): Proposal of a new cognitive self-report questionnaire for pediatric multiple sclerosis patients 140
Quantification of normal-appearing white matter damage in early relapse-onset multiple sclerosis through neurite orientation dispersion and density imaging 137
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 135
Effects of disease modifying therapies on brain and grey matter atrophy in relapsing remitting multiple sclerosis 134
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis 133
Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques 132
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis 128
Hematoma of Meckel's cave: a rare possible symptomatic trigeminal neuralgia 126
A novel mutation in ABCD1 unveils different clinical phenotypes in a family with adrenoleukodystrophy 124
Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis 120
Idiopathic hypertrophic cranial pachymeningitis as a rare cause of status epilepticus 119
Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study 114
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 113
Ophthalmoplegic migraine: could electroencephalogram still be a useful tool to better understand the pathogenetic mechanism? 108
Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosis 107
Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre 105
Multiple sclerosis diagnosis: a biologically driven perspective 104
Very late-onset recurrent myelitis in a patient diagnosed with antiphospholipid syndrome: A puzzle of autoimmunity 101
Ketogenic diet in migraine treatment: a brief but ancient history 94
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic 94
Monoaminergic network abnormalities are associated with fatigue in pediatric multiple sclerosis 90
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis 88
Cerebellar pathology and disability worsening in relapsing‐remitting multiple sclerosis: a retrospective analysis from the CombiRx trial 88
Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre 87
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 87
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 82
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities 82
Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers 81
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 79
Emerging Perspectives on MRI Application in Multiple Sclerosis: Moving from Pathophysiology to Clinical Practice 77
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis 74
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 74
Dynamics of choroid plexus volume is associated with the presence and development of fatigue in multiple sclerosis 71
Chronic Active Lesions and Larger Choroid Plexus Explain Cognition and Fatigue in Multiple Sclerosis 68
Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis 67
Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis 66
Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein–immunoglobulin G-associated Disease 63
Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis 61
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 60
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 60
Influence of cardiorespiratory fitness and MRI measures of neuroinflammation on hippocampal volume in multiple sclerosis 60
Behind the scenes: exploring neurological journal editors’ work habits, decisions, and potential sources of conflict of interest 59
Spinal Cord Abnormalities in Early Pediatric Multiple Sclerosis 59
Soma and neurite density abnormalities of paramagnetic rim lesions and core-sign lesions in multiple sclerosis 59
Subventricular Zone Microstructure in Pediatric‐Onset Multiple Sclerosis 57
Cervical spinal cord gray matter damage predicts disability worsening in multiple sclerosis: a longitudinal study 56
Disability worsening outcome in multiple sclerosis based on EDSS: does half a point matter? 56
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 55
A Fully Automatic Method to Segment Choroid Plexuses in Multiple Sclerosis Using Conventional MRI Sequences 53
Paramagnetic rim and core sign lesions in paediatric multiple sclerosis patients 53
Assessment of central vein sign and paramagnetic rim lesions in pediatric multiple sclerosis 52
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study 48
The diagnostic workup of children with the radiologically isolated syndrome differs by age and by sex 46
Tumefactive demyelinating lesions: a challenging first manifestation of multiple sclerosis 39
Thalamic nuclei volume partially mediates the effects of aerobic capacity on fatigue in people with multiple sclerosis 38
The ageing central nervous system in multiple sclerosis: the imaging perspective 36
Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study 35
Structural and functional imaging features of cognitive phenotypes in pediatric multiple sclerosis 35
null 18
Totale 7.289
Categoria #
all - tutte 21.551
article - articoli 21.274
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021211 0 0 0 0 0 16 8 45 45 43 43 11
2021/2022390 8 14 36 19 37 46 24 33 49 15 29 80
2022/2023359 55 29 22 36 48 47 7 29 45 14 20 7
2023/2024382 11 28 27 44 37 29 40 22 34 33 36 41
2024/20251.624 12 95 77 57 222 37 54 146 107 84 308 425
2025/20263.720 357 570 1.055 1.174 559 5 0 0 0 0 0 0
Totale 7.289